• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

FOXA2 通过调节人乳腺癌中 E-钙黏蛋白和 ZEB2 的转录来抑制上皮间质转化。

FOXA2 attenuates the epithelial to mesenchymal transition by regulating the transcription of E-cadherin and ZEB2 in human breast cancer.

机构信息

State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Biology, Collaborative Innovation Center for Chemistry and Molecular Medicine, Hunan University, Changsha, Hunan 410082, China.

Department of Pathology, Hunan Provincial Tumor Hospital, Changsha, Hunan 410013, China.

出版信息

Cancer Lett. 2015 Jun 1;361(2):240-50. doi: 10.1016/j.canlet.2015.03.008. Epub 2015 Mar 14.

DOI:10.1016/j.canlet.2015.03.008
PMID:25779673
Abstract

The Forkhead Box A2 (FOXA2) transcription factor is required for embryonic development and for normal functions of multiple adult tissues, in which the maintained expression of FOXA2 is usually related to preventing the progression of malignant transformation. In this study, we found that FOXA2 prevented the epithelial to mesenchymal transition (EMT) in human breast cancer. We observed a strong correlation between the expression levels of FOXA2 and the epithelial phenotype. Knockdown of FOXA2 promoted the mesenchymal phenotype, whereas stable overexpression of FOXA2 attenuated EMT in breast cancer cells. FOXA2 was found to endogenously bind to and stimulate the promoter of E-cadherin that is crucial for epithelial phenotype of the tumor cells. Meanwhile, FOXA2 prevented EMT of breast cancer cells by repressing the expression of EMT-related transcription factor ZEB2 through recruiting a transcriptional corepressor TLE3 to the ZEB2 promoter. The stable overexpression of FOXA2 abolished metastasis of breast cancer cells in vivo. This study confirmed that FOXA2 inhibited EMT in breast cancer cells by regulating the transcription of EMT-related genes such as E-cadherin and ZEB2.

摘要

叉头框蛋白 A2(FOXA2)转录因子对于胚胎发育和多种成年组织的正常功能是必需的,在这些组织中,FOXA2 的持续表达通常与防止恶性转化的进展有关。在这项研究中,我们发现 FOXA2 可防止人乳腺癌中的上皮间质转化(EMT)。我们观察到 FOXA2 的表达水平与上皮表型之间存在很强的相关性。FOXA2 的敲低促进了间充质表型,而 FOXA2 的稳定过表达则减弱了乳腺癌细胞的 EMT。FOXA2 被发现可内源性结合并刺激 E-钙粘蛋白启动子,E-钙粘蛋白对于肿瘤细胞的上皮表型至关重要。同时,FOXA2 通过招募转录核心抑制子 TLE3 到 ZEB2 启动子来抑制 EMT 相关转录因子 ZEB2 的表达,从而防止乳腺癌细胞的 EMT。FOXA2 的稳定过表达可消除体内乳腺癌细胞的转移。这项研究证实,FOXA2 通过调节 EMT 相关基因如 E-钙粘蛋白和 ZEB2 的转录来抑制乳腺癌细胞中的 EMT。

相似文献

1
FOXA2 attenuates the epithelial to mesenchymal transition by regulating the transcription of E-cadherin and ZEB2 in human breast cancer.FOXA2 通过调节人乳腺癌中 E-钙黏蛋白和 ZEB2 的转录来抑制上皮间质转化。
Cancer Lett. 2015 Jun 1;361(2):240-50. doi: 10.1016/j.canlet.2015.03.008. Epub 2015 Mar 14.
2
ZEB2 upregulates integrin α5 expression through cooperation with Sp1 to induce invasion during epithelial-mesenchymal transition of human cancer cells.ZEB2 通过与 Sp1 合作上调整合素 α5 的表达,诱导人癌细胞上皮-间充质转化中的侵袭。
Carcinogenesis. 2012 Mar;33(3):563-71. doi: 10.1093/carcin/bgs005. Epub 2012 Jan 6.
3
Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer.在乳腺癌中,多梳蛋白 Mel-18 的缺失通过下调 miR-205 增强 ZEB1 和 ZEB2 的表达,从而促进上皮-间充质转化。
Oncogene. 2014 Mar 6;33(10):1325-35. doi: 10.1038/onc.2013.53. Epub 2013 Mar 11.
4
The Cdc42/Rac1 regulator CdGAP is a novel E-cadherin transcriptional co-repressor with Zeb2 in breast cancer.Cdc42/Rac1调节因子CdGAP是一种在乳腺癌中与Zeb2共同作用的新型E-钙黏蛋白转录共抑制因子。
Oncogene. 2017 Jun 15;36(24):3490-3503. doi: 10.1038/onc.2016.492. Epub 2017 Jan 30.
5
ZEB2-Sp1 cooperation induces invasion by upregulating cadherin-11 and integrin α5 expression.ZEB2-Sp1 合作通过上调钙黏蛋白 11 和整合素 α5 的表达诱导侵袭。
Carcinogenesis. 2014 Feb;35(2):302-14. doi: 10.1093/carcin/bgt340. Epub 2013 Oct 15.
6
FOXM1 promotes the epithelial to mesenchymal transition by stimulating the transcription of Slug in human breast cancer.FOXM1 通过刺激 Slug 在人乳腺癌中的转录促进上皮间质转化。
Cancer Lett. 2013 Oct 28;340(1):104-12. doi: 10.1016/j.canlet.2013.07.004. Epub 2013 Jul 12.
7
MiR-200a promotes epithelial-mesenchymal transition of endometrial cancer cells by negatively regulating FOXA2 expression.微小RNA-200a通过负向调节叉头框蛋白A2的表达促进子宫内膜癌细胞的上皮-间质转化。
Pharmazie. 2017 Nov 1;72(11):694-699. doi: 10.1691/ph.2017.7649.
8
Interplay between KLF4 and ZEB2/SIP1 in the regulation of E-cadherin expression.KLF4 与 ZEB2/SIP1 在调控 E-钙黏蛋白表达中的相互作用。
Biochem Biophys Res Commun. 2013 Feb 22;431(4):652-7. doi: 10.1016/j.bbrc.2013.01.070. Epub 2013 Jan 29.
9
BCL6 induces EMT by promoting the ZEB1-mediated transcription repression of E-cadherin in breast cancer cells.BCL6 通过促进 ZEB1 介导的 E-钙黏蛋白转录抑制在乳腺癌细胞中诱导 EMT。
Cancer Lett. 2015 Sep 1;365(2):190-200. doi: 10.1016/j.canlet.2015.05.029. Epub 2015 Jun 3.
10
ZEB2 promotes vasculogenic mimicry by TGF-β1 induced epithelial-to-mesenchymal transition in hepatocellular carcinoma.ZEB2通过TGF-β1诱导的上皮-间质转化促进肝细胞癌的血管生成拟态。
Exp Mol Pathol. 2015 Jun;98(3):352-9. doi: 10.1016/j.yexmp.2015.03.030. Epub 2015 Mar 26.

引用本文的文献

1
FOXP2 suppresses gastric cancer progression by transcriptionally repressing FBXW2 via WASL degradation.FOXP2通过WASL降解转录抑制FBXW2,从而抑制胃癌进展。
Cell Death Discov. 2025 Jul 28;11(1):348. doi: 10.1038/s41420-025-02643-1.
2
FOXA2 loss results in an increase of endometriosis development and LIF reveals a therapeutic effect for endometriosis.叉头框蛋白A2(FOXA2)缺失导致子宫内膜异位症发展增加,白血病抑制因子(LIF)对子宫内膜异位症具有治疗作用。
FASEB J. 2025 Mar 15;39(5):e70436. doi: 10.1096/fj.202403182R.
3
The Role of the Fox Gene in Breast Cancer Progression.
Fox基因在乳腺癌进展中的作用。
Int J Mol Sci. 2025 Feb 7;26(4):1415. doi: 10.3390/ijms26041415.
4
Shared genetics between breast cancer and predisposing diseases identifies novel breast cancer treatment candidates.乳腺癌与易患疾病之间的共享遗传基因确定了新的乳腺癌治疗候选物。
Hum Genomics. 2024 Nov 14;18(1):124. doi: 10.1186/s40246-024-00688-4.
5
Shared genetics between breast cancer and predisposing diseases identifies novel breast cancer treatment candidates.乳腺癌与易感疾病之间的共同基因可识别出新的乳腺癌治疗候选靶点。
Res Sq. 2024 Jun 21:rs.3.rs-4536370. doi: 10.21203/rs.3.rs-4536370/v1.
6
Single-cell Transcriptomic Studies Unveil Potential Nodes of the Notochord Gene Regulatory Network.单细胞转录组研究揭示了脊索基因调控网络的潜在节点。
Integr Comp Biol. 2024 Nov 21;64(5):1194-1213. doi: 10.1093/icb/icae084.
7
FOXA1 and FOXA2: the regulatory mechanisms and therapeutic implications in cancer.叉头框蛋白A1(FOXA1)和叉头框蛋白A2(FOXA2):癌症中的调控机制及治疗意义
Cell Death Discov. 2024 Apr 11;10(1):172. doi: 10.1038/s41420-024-01936-1.
8
FOXA2 activates HIF2α expression to promote tumor progression and is regulated by the E3 ubiquitin ligase VHL in renal cell carcinoma.FOXA2 通过激活 HIF2α 的表达促进肿瘤进展,并受肾癌中 E3 泛素连接酶 VHL 的调控。
J Biol Chem. 2024 Jan;300(1):105535. doi: 10.1016/j.jbc.2023.105535. Epub 2023 Dec 10.
9
FOXA2 Suppression by TRIM36 Exerts Anti-Tumor Role in Colorectal Cancer Via Inducing NRF2/GPX4-Regulated Ferroptosis.FOXA2 通过抑制 TRIM36 在结直肠癌中发挥抑瘤作用,通过诱导 NRF2/GPX4 调节的铁死亡。
Adv Sci (Weinh). 2023 Dec;10(35):e2304521. doi: 10.1002/advs.202304521. Epub 2023 Oct 24.
10
Promotes Colorectal Cancer Progression and Targets BCL2-Associated X (BAX) Protein.促进结直肠癌进展并作用于BCL2相关X蛋白(BAX)
Iran J Public Health. 2023 Feb;52(2):306-314. doi: 10.18502/ijph.v52i2.11883.